Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1996 Jun;60(6):676–680. doi: 10.1136/jnnp.60.6.676

Cognitive impairments of alcoholic cirrhotic patients: correlation with endogenous benzodiazepine receptor ligands and increased affinity of platelet receptors.

F Kapczinski 1, H V Curran 1, R Przemioslo 1, R Williams 1, E Fluck 1, C Fernandes 1, S E File 1
PMCID: PMC1073954  PMID: 8648337

Abstract

OBJECTIVES--To determine whether differences in cognitive function between alcoholic and non-alcoholic cirrhotic patients relate to differences in endogenous ligands for the benzodiazepine receptor and/or benzodiazepine binding. METHODS--Seventeen grade-I hepatic encephalopathic patients (nine alcoholic, eight non-alcoholic) were compared with 10 matched controls on plasma concentrations of endogenous ligands for the neuronal benzodiazepine receptor, benzodiazepine binding in platelets, and performance on tests of cognitive function. RESULTS--Both groups of patients were impaired on verbal recall and on reaction time tasks compared with controls; alcoholic patients were also impaired on Reitan's trails test and digit cancellation. Four of the 17 patients had detectable concentrations of endogenous benzodiazepine ligands and they were more impaired than other patients on trails and cancellation tests. The groups did not differ in the density of benzodiazepine platelet receptors, but receptor affinity was higher in alcoholic patients than in controls; furthermore, receptor affinity correlated with the time to complete the cancellation task and with reaction time. CONCLUSION--Alcoholic cirrhotic patients may have enhanced concentrations of ligands for neuronal and peripheral benzodiazepine receptors and these may contribute to cognitive impairments in these patients.

Full text

PDF
678

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bansky G., Meier P. J., Riederer E., Walser H., Ziegler W. H., Schmid M. Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans. Gastroenterology. 1989 Sep;97(3):744–750. doi: 10.1016/0016-5085(89)90647-1. [DOI] [PubMed] [Google Scholar]
  2. Bruha R., Marecek Z., Brodanova M., Votruba M. Flumazenil as a diagnostic test for latent hepatic encephalopathy. J Hepatol. 1994 Jun;20(6):844–844. doi: 10.1016/s0168-8278(05)80161-8. [DOI] [PubMed] [Google Scholar]
  3. Curran H. V. Benzodiazepines, memory and mood: a review. Psychopharmacology (Berl) 1991;105(1):1–8. doi: 10.1007/BF02316856. [DOI] [PubMed] [Google Scholar]
  4. Diodati G., Bonetti P., Noventa F., Casarin C., Rugge M., Scaccabarozzi S., Tagger A., Pollice L., Tremolada F., Davite C. Treatment of chronic hepatitis C with recombinant human interferon-alpha 2a: results of a randomized controlled clinical trial. Hepatology. 1994 Jan;19(1):1–5. [PubMed] [Google Scholar]
  5. Ferrero P., Rocca P., Gualerzi A., Benna P., Enrichens F., Olivero G., Mao P., Ravizza L., Bergamasco B. A study of 3H-PK 11,195 binding to "peripheral-type" benzodiazepine receptors on human lymphocytes. Evidence of decreased binding in hepatic encephalopathy. J Neurol Sci. 1991 Apr;102(2):209–219. doi: 10.1016/0022-510x(91)90071-e. [DOI] [PubMed] [Google Scholar]
  6. Gavish M., Fares F. The effect of freezing and thawing or of detergent treatment on peripheral benzodiazepine binding: the possible existence of an endogenous ligand. Eur J Pharmacol. 1985 Jan 2;107(2):283–284. doi: 10.1016/0014-2999(85)90072-x. [DOI] [PubMed] [Google Scholar]
  7. Gavish M., Katz Y., Bar-Ami S., Weizman R. Biochemical, physiological, and pathological aspects of the peripheral benzodiazepine receptor. J Neurochem. 1992 May;58(5):1589–1601. doi: 10.1111/j.1471-4159.1992.tb10030.x. [DOI] [PubMed] [Google Scholar]
  8. Gavish M., Weizman A., Karp L., Tyano S., Tanne Z. Decreased peripheral benzodiazepine binding sites in platelets of neuroleptic-treated schizophrenics. Eur J Pharmacol. 1986 Feb 18;121(2):275–279. doi: 10.1016/0014-2999(86)90500-5. [DOI] [PubMed] [Google Scholar]
  9. Golombok S., Moodley P., Lader M. Cognitive impairment in long-term benzodiazepine users. Psychol Med. 1988 May;18(2):365–374. doi: 10.1017/s0033291700007911. [DOI] [PubMed] [Google Scholar]
  10. Grimm G., Ferenci P., Katzenschlager R., Madl C., Schneeweiss B., Laggner A. N., Lenz K., Gangl A. Improvement of hepatic encephalopathy treated with flumazenil. Lancet. 1988 Dec 17;2(8625):1392–1394. doi: 10.1016/s0140-6736(88)90587-9. [DOI] [PubMed] [Google Scholar]
  11. Kapczinski F., Sherman D., Williams R., Lader M., Curran V. Differential effects of flumazenil in alcoholic and nonalcoholic cirrhotic patients. Psychopharmacology (Berl) 1995 Jul;120(2):220–226. doi: 10.1007/BF02246197. [DOI] [PubMed] [Google Scholar]
  12. Krueger K. E., Papadopoulos V. Peripheral-type benzodiazepine receptors mediate translocation of cholesterol from outer to inner mitochondrial membranes in adrenocortical cells. J Biol Chem. 1990 Sep 5;265(25):15015–15022. [PubMed] [Google Scholar]
  13. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  14. Lund J. Radioreceptor assay for benzodiazepines in biological fluids using a new dry and stable receptor preparation. Scand J Clin Lab Invest. 1981 May;41(3):275–280. doi: 10.3109/00365518109092045. [DOI] [PubMed] [Google Scholar]
  15. Olasmaa M., Rothstein J. D., Guidotti A., Weber R. J., Paul S. M., Spector S., Zeneroli M. L., Baraldi M., Costa E. Endogenous benzodiazepine receptor ligands in human and animal hepatic encephalopathy. J Neurochem. 1990 Dec;55(6):2015–2023. doi: 10.1111/j.1471-4159.1990.tb05790.x. [DOI] [PubMed] [Google Scholar]
  16. Pomier-Layrargues G., Giguère J. F., Lavoie J., Perney P., Gagnon S., D'Amour M., Wells J., Butterworth R. F. Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial. Hepatology. 1994 Jan;19(1):32–37. [PubMed] [Google Scholar]
  17. Stein S. F., Harker L. A. Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis. J Lab Clin Med. 1982 Feb;99(2):217–230. [PubMed] [Google Scholar]
  18. Zhang Z. M., Qiu F. Z., Chen X. P. [Experimental studies on peripheral-type benzodiazepine receptors in brain in rats with hepatic encephalopathy]. Zhonghua Wai Ke Za Zhi. 1994 Jan;32(1):37–40. [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES